Dr. Elham Kazemirad | Treatment for Infectious Diseases | Excellence in Research

Published on by Infectious

Dr. Elham Kazemirad | Treatment for Infectious Diseases | Excellence in Research

Associate Professor at Tehran University of Medical Sciences, Iran

Dr. Elham Kazemirad is a renowned Associate Professor at the Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences. Her research bridges clinical and molecular diagnostics, with a central focus on Treatment for Infectious Diseases. Over the years, her contributions have emphasized Treatment for Infectious Diseases across leishmaniasis, Acanthamoeba keratitis, and protozoan infections. Her work consistently explores innovative diagnostic and therapeutic strategies, reinforcing global capabilities in Treatment for Infectious Diseases. With a dynamic presence in academia, she has dedicated her career to advancing Treatment for Infectious Diseases through cutting-edge molecular biology, gene expression studies, and nanoparticle drug delivery. Dr. Kazemirad’s leadership and research continue shaping new pathways for Treatment for Infectious Diseases in both clinical and research settings.

Professional Profile 

ORCID | Google Scholar

Education

Dr. Kazemirad holds a Ph.D., M.Sc., B.Sc., and Associate Degree in Medical Parasitology and Laboratory Sciences, all from top Iranian medical universities. Her Ph.D. thesis pioneered gene profiling in Leishmania tropica and explored mechanisms of drug resistance, directly contributing to Treatment for Infectious Diseases. Throughout her academic path, Treatment for Infectious Diseases remained a core theme, evident in her early thesis on PCR diagnostics and parasite detection. Her educational foundation was rigorously rooted in scientific innovation and clinical relevance, always aimed at improving Treatment for Infectious Diseases. This background has propelled her to become a thought leader whose educational milestones support groundbreaking discoveries in the Treatment for Infectious Diseases field.

Experience

Dr. Kazemirad has served as an Assistant and Associate Professor, and lab supervisor, contributing significantly to Treatment for Infectious Diseases . Her clinical laboratory leadership includes molecular diagnosis of parasitic diseases, microbial keratitis, and more, always reinforcing effective Treatment for Infectious Diseases. She combines teaching, clinical, and administrative roles to shape future parasitologists and advance diagnostics. At both Tehran University of Medical Sciences and Pasteur Institute of Iran, her dedication has been a cornerstone in Treatment for Infectious Diseases. She mentors students and leads research initiatives that redefine how Treatment for Infectious Diseases is applied and understood across academic, diagnostic, and healthcare platforms.

Research Interest

Dr. Kazemirad’s primary research interests center on drug resistance mechanisms, molecular diagnostics, and nanomedicine all critical for effective Treatment for Infectious Diseases. Her passion for Treatment for Infectious Diseases drives projects involving gene expression in pathogens and the development of novel therapeutics. With expertise in biotechnology, immunology, and phylogenetics, she investigates the molecular basis of resistance and innovative drug delivery systems. Treatment for Infectious Diseases is not only her research focus but her mission. By integrating bioinformatics, molecular assays, and nanoparticle therapeutics, her research contributes vital knowledge and practical tools to improve Treatment for Infectious Diseases, especially among vulnerable and immunocompromised populations.

Awards and Honors

Dr. Kazemirad has been consistently recognized for her academic excellence and innovation in Treatment for Infectious Diseases. She was ranked first in multiple academic programs and received distinctions for her graduate work in drug-resistant Leishmania. Her work in Treatment for Infectious Diseases has been honored through leadership roles in scientific congresses and editorial positions in top journals. These honors reflect her relentless commitment to advancing Treatment for Infectious Diseases through translational research and public health applications. The prestigious recognition from both Iranian and international institutions underscores her profound impact on Treatment for Infectious Diseases and her standing as a key contributor in parasitological and biomedical sciences.

Research Skills

Dr. Kazemirad is proficient in molecular diagnostics, gene expression analysis, animal modeling, and nanoparticle-based therapeutics, all pivotal for enhancing Treatment for Infectious Diseases. Her skill set includes advanced techniques such as RT-PCR, Western blotting, cloning, proteomics, ELISA, gene silencing, and next-generation sequencing. Each technique is applied to understand, monitor, and improve Treatment for Infectious Diseases. Her expertise extends to developing diagnostic platforms for Acanthamoeba and Leishmania, along with testing novel compounds and nanoparticles. Treatment for Infectious Diseases is the core of her methodological approach, combining lab innovation with clinical relevance to transform how these diseases are managed and treated across diverse populations.

Publications

Title: Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice
Authors: Saberi, M.; Latifi, A.; Golkar, M.; Fard-Esfahani, P.; Mohtasebi, S.; Teimouri, A.; Afshar, M.J.A.; Kazemirad, E.; Mohebali, M.
Journal: PLoS Neglected Tropical Diseases

Title: High Prevalence of Enterocytozoon bieneusi Genotype BEB6 in Wild Boars in Lorestan Province, Iran: Potential Source of Zoonotic Transmission
Authors: Javanmard, E.; Mohammad Rahimi, H.; Taghipour, A.; Nemati, S.; Mohebali, M.; Rezaeian, M.; Badrifar, A.; Kazemirad, E.; Mirjalali, H.
Journal: Iranian Journal of Parasitology

Title: Molecular Identification of Nematodes (Superfamily: Strongylida) Traced in Herbivores Excrement in the Wildlife from Western Iran
Authors: Vafaei, M.R.; Safaie, M.; Kazemirad, E.; Mirjalali, H.; Askari, Z.; Mohebali, M.; Mowlavi, G.
Journal: SSRN

Title: Prevalence of free-living amoebae in five rivers associated with high human activity in Tehran province, Iran
Authors: Javanmard, E.; Kazemirad, E.; Rahimi, H.M.; Mohebali, M.; Rezaeian, M.; Alimohammadi, M.; Mirjalali, H.
Journal: Journal of Water and Health

Title: Transcriptional alterations of virulence factors in Leishmania major clinical isolates harboring Leishmania RNA virus 2 (LRV2)
Authors: Sabeti, S.; Koosha, M.; Kazemirad, E.; Mirabedini, Z.; Mohebali, M.; Saberi, R.; Fakhar, M.; Hajjaran, H.
Journal: BMC Infectious Diseases

CONCLUSION

Dr. Elham Kazemirad’s career epitomizes dedication to the Treatment for Infectious Diseases. Through her education, research, and professional engagements, she has elevated global understanding of parasitic diseases and their therapies. Her work integrates basic science and clinical innovation to offer novel solutions for Treatment for Infectious Diseases. From academic contributions to pioneering diagnostics and therapies, her impact is profound and ongoing. She remains a key influencer in shaping policies, mentoring future scientists, and leading research that targets resistant pathogens. As Treatment for Infectious Diseases continues to challenge global health, her expertise remains vital in guiding next-generation therapeutic advancements and public health solutions.

Dayu Liu – Diagnosis of Infectious Diseases – Best Researcher Award

Published on by Infectious

Dayu Liu - Diagnosis of Infectious Diseases - Best Researcher Award

the Second Affiliated Hospital, School of Medicine, South China University of Technology - China

AUTHOR PROFILE

SCOPUS

EARLY ROOTS IN MEDICAL SCIENCE 🧬

Dr. Dayu Liu's foundational journey into the world of science began with a Bachelor of Science in Clinical Medicine from Dalian Medical University, where he cultivated a strong interest in pathology and diagnostics. He further refined his expertise through a Master’s in Pathology at the same university, driven by his passion for biomedical research. Motivated to explore the frontiers of analytical innovation, Dr. Liu pursued a Ph.D. in Analytical Chemistry at the University of Chinese Academy of Sciences (UCAS), where his thesis focused on microfluidic chip research. This advanced study marked the inception of his specialization in micro-analytical systems, a field directly contributing to the advancement of the Diagnosis of Infectious Diseases. Through these early academic pursuits, Dr. Liu not only gained technical mastery but also a comprehensive understanding of how microfluidic systems could be applied to rapidly detect and monitor pathogens. These experiences laid the scientific and clinical groundwork that now defines his work. Today, his early education continues to inform his cutting-edge innovations in laboratory medicine, exemplifying how fundamental medical training can evolve into pioneering research impacting the Diagnosis of Infectious Diseases globally.

MICROFLUIDIC BREAKTHROUGHS IN DIAGNOSTICS 🔬

Dr. Liu’s groundbreaking work in microfluidic chip technology stands at the intersection of engineering and medicine, revolutionizing the Diagnosis of Infectious Diseases. As Director of the Microfluidic In Vitro Diagnostics Laboratory at the Second Affiliated Hospital of South China University of Technology, he leads transformative research in developing portable, rapid, and precise diagnostic platforms. His postdoctoral tenure at the Hong Kong University of Science and Technology provided him with essential experience in micro-analytical systems, which he has since applied to real-world healthcare challenges. By engineering chips capable of analyzing minute biological samples, Dr. Liu has enabled quicker and more cost-effective diagnostics, especially vital for early-stage detection of infectious diseases. His work in this domain includes the creation of high-content diagnostic systems that can process large volumes of patient data, thereby improving the accuracy and speed of infectious disease detection. These advancements are essential for responding to disease outbreaks and managing global health emergencies. His technology also supports personalized medicine, ensuring that patients receive treatments tailored to their biological profiles. Through microfluidics, Dr. Liu is not only enhancing laboratory workflows but also redefining the operational standards for the Diagnosis of Infectious Diseases in both clinical and remote settings.

PIONEERING RESEARCH AND GLOBAL IMPACT 🌍

Dr. Dayu Liu has emerged as a leading voice in the global scientific community through his contributions to diagnostic research. His work has significant implications for public health, particularly in the Diagnosis of Infectious Diseases, where accurate and timely detection can mean the difference between containment and catastrophe. As a principal investigator for five National Natural Science Foundation of China (NSFC) General Program Grants and over ten provincial and municipal research projects, Dr. Liu has secured consistent support for his groundbreaking research. His studies bridge the gap between laboratory innovation and clinical application, especially in under-resourced healthcare systems. His focus on developing microfluidic chip-based diagnostics has enabled large-scale screening and epidemiological surveillance, bolstering global preparedness for infectious disease threats. Through collaborations with international journals and institutions, he disseminates knowledge that transcends borders. His scholarly contributions, with over 50 peer-reviewed articles, have introduced novel methodologies now employed by diagnostics labs around the world. In championing scientific transparency and reproducibility, Dr. Liu's research continues to inform policy and practice related to the Diagnosis of Infectious Diseases, illustrating the role of academic innovation in safeguarding human health on a global scale.

TECHNOLOGICAL INNOVATION IN LABORATORY MEDICINE ⚙️

Technological ingenuity is at the heart of Dr. Liu's contributions to laboratory medicine, particularly concerning the Diagnosis of Infectious Diseases. By designing and engineering microfluidic platforms, he has pushed the boundaries of what’s possible in diagnostic technology. His innovations offer compact, easy-to-use, and highly accurate tools that are reshaping how infectious agents are identified and quantified. As a researcher at the Second Affiliated Hospital of South China University of Technology, he continually translates engineering principles into medical breakthroughs. His laboratory focuses on producing integrated systems capable of simultaneously analyzing multiple biomarkers—crucial for differentiating between viral and bacterial infections quickly. With more than 20 patents to his name, Dr. Liu's inventions extend beyond academia, providing commercial and clinical avenues for next-generation diagnostics. These systems have already shown effectiveness in detecting diseases like COVID-19, dengue, and tuberculosis, aligning with global efforts to strengthen disease surveillance. Through innovation in biosensors, signal amplification, and sample handling, his lab sets new standards in point-of-care diagnostics. As infectious diseases remain a persistent threat, Dr. Liu’s technology ensures that the Diagnosis of Infectious Diseases becomes more responsive, affordable, and accessible, fulfilling urgent global health needs.

MENTORSHIP AND ACADEMIC LEADERSHIP 🎓

Beyond the laboratory bench, Dr. Liu plays a vital role in shaping future scientific leaders. As an advisor for both Master's and Ph.D. students at South China University of Technology, he actively mentors the next generation of researchers, many of whom are now working on projects directly related to the Diagnosis of Infectious Diseases. His mentorship philosophy emphasizes rigorous methodology, interdisciplinary collaboration, and ethical responsibility. Under his guidance, students are trained in advanced diagnostic technologies, including microfluidics, bioinformatics, and molecular biology. Dr. Liu encourages his mentees to bridge research and real-world application, ensuring their work remains clinically relevant. He has cultivated a thriving academic environment where curiosity and innovation are prioritized. His influence as a mentor extends through co-authored publications, joint patent applications, and international conference presentations. Many of his students have gone on to secure academic and industry positions, contributing to global efforts in disease detection and management. Dr. Liu’s dedication to education not only amplifies his impact but also ensures that the field of Diagnosis of Infectious Diseases continues to evolve, benefiting from the fresh perspectives and skills of well-trained young scientists.

SCIENTIFIC ACHIEVEMENTS AND RECOGNITION 🏅

Dr. Dayu Liu’s prolific scientific output and numerous accolades reflect his standing in the international research community. With over 50 peer-reviewed articles in renowned journals such as Advanced Science, Lab on a Chip, and Analytical Chemistry, his work has consistently advanced the field of Diagnosis of Infectious Diseases. His research is widely cited and has influenced diagnostic protocols and policy formulations. Dr. Liu’s intellectual property portfolio includes more than 20 patents, many of which have practical applications in commercial diagnostic kits. These contributions have earned him regional and national recognition, solidifying his reputation as a leading innovator in diagnostic medicine. He is frequently invited to speak at global conferences and serve on editorial boards, further underscoring the international value of his research. Awards from scientific societies and funding bodies have validated the impact of his work on both clinical practice and public health. Dr. Liu’s achievements illustrate a career committed to solving real-world problems through scientific inquiry. His advancements continue to inspire other researchers and contribute to a more precise, rapid, and scalable approach to the Diagnosis of Infectious Diseases, thereby enhancing disease control and patient care globally.

VISION FOR THE FUTURE OF DIAGNOSTICS 🔮

Looking forward, Dr. Liu envisions a diagnostic landscape where rapid, decentralized, and personalized testing becomes the norm, especially in the realm of the Diagnosis of Infectious Diseases. His future work aims to integrate artificial intelligence and machine learning into microfluidic systems to enable predictive diagnostics. By harnessing big data and cloud-based platforms, he aspires to create real-time monitoring tools that can anticipate outbreaks before they spread. His lab is currently exploring novel biosensors capable of detecting emerging pathogens with unprecedented sensitivity. Dr. Liu also plans to expand collaborations with international institutions to promote technology transfer and equitable access to diagnostics in low-resource settings. His commitment to sustainable and scalable solutions will be critical in tackling future pandemics and antimicrobial resistance. Through continuous innovation and interdisciplinary synergy, Dr. Liu is determined to make diagnostics more inclusive, accurate, and efficient. As he charts the path forward, his work remains grounded in one central mission: advancing the Diagnosis of Infectious Diseases to protect global health. His legacy will not only be measured in patents or publications but in lives saved and healthcare systems strengthened through intelligent, accessible diagnostic science.

NOTABLE PUBLICATION

  • Title: Pheno-Molecular Testing Enabled by Multiplex Droplet Digital PCR for Rapid and High-Content Detection of Carbapenem-Resistant Enterobacterales
    Journal: Analytical Chemistry
    Authors: (Author names not specified in the input — please provide or clarify if needed)

  • Title: Droplet Pairing-Merging Enabled Digital RPA-CRISPR/Cas12a (DIMERIC) Assay for Rapid and Precise Quantification of Hepatitis B Virus DNA
    Journal: Biosensors and Bioelectronics
    Authors: (Author names not specified in the input)

  • Title: Automated Droplet Ejection from a Digital Microfluidics Sample Pretreatment Device Enables Batch-Mode Chemiluminescence Immunoassay
    Journal: Analytical Chemistry
    Authors: (Author names not specified in the input)

  • Title: Forming Single-Cell-Derived Colon Cancer Organoid Arrays on a Microfluidic Chip for High Throughput Tumor Heterogeneity Analysis
    Journal: ACS Biomaterials Science and Engineering
    Authors: (Author names not specified in the input)

  • Title: Selective Expansion of Renal Cancer Stem Cells Using Microfluidic Single-Cell Culture Arrays for Anticancer Drug Testing
    Journal: Lab on a Chip
    Authors: (Author names not specified in the input)

Moncef Chouaibi – Treatment for Infectious Diseases – Best Academic Researcher Award

Published on by Infectious

Moncef Chouaibi - Treatment for Infectious Diseases - Best Academic Researcher Award 

Higher School of Food Industries of Tunis - Tunisia

AUTHOR PROFILE

ORCID

🎓 EARLY ACADEMIC PURSUITS

Professor Moncef Chouaïbi's academic journey reflects a strong foundation in mathematical sciences and food engineering. He began with a Bachelor of Mathematics from 1996 to 2000, which laid the groundwork for his analytical approach in later scientific explorations. He pursued an engineering diploma, master’s, and ultimately a PhD in Food Industries between 2000 and 2013 from the University of Carthage and the University of Salerno. His doctoral studies focused on food engineering and preservation technologies, critical to public health, especially in regions facing foodborne infections. During these formative years, he developed a keen interest in the optimization of extraction processes, thermal food treatment, and encapsulation of bioactive compounds—techniques that today underpin innovations in antimicrobial food systems. His early academic path emphasized both theoretical mastery and applied research, equipping him with the scientific literacy and lab-based expertise to address complex problems in food safety and infectious disease management. His studies incorporated methodologies that enhance food functionality while limiting pathogen transmission—a core concern in infectious disease control. This period was not just a phase of learning but also a springboard for his later contributions to microbiologically safe and nutritionally enhanced food products.

🧪 PROFESSIONAL ENDEAVORS IN FOOD SCIENCE

Since the early stages of his career, Professor Chouaïbi has devoted himself to the advancement of food engineering with a strong focus on safety, stability, and nutrition. Starting as a Senior Research Fellow in Tunis and later in Salerno, Italy, he quickly transitioned into academic leadership as an Assistant Professor and eventually as a full Professor at the Higher School of Food Industries of Tunis. His teaching and mentoring have supported a new generation of scientists, but it is his research that sets him apart. He has actively explored the use of natural preservatives, bioactive components, and rheological food properties to improve food quality and safety. This work is especially relevant in developing countries where infectious diseases are often exacerbated by compromised food systems. By modeling heat and mass transfer, Professor Chouaïbi has helped design preservation techniques that reduce microbial load in food, directly contributing to infectious disease prevention. He has also collaborated with biotechnology and food chemistry experts to create functional foods that boost immune responses. His hands-on approach and strategic focus on real-world applications of food science make his professional journey a beacon for interdisciplinary innovation in nutrition and public health.

🧬 RESEARCH ON FUNCTIONAL FOODS & BIOACTIVE COMPOUNDS

Professor Moncef Chouaïbi has established himself as a pioneering researcher in the field of functional foods and bioactive compound extraction. His studies on antioxidant-rich oils, including those derived from pumpkin, celery, and Zizyphus lotus, demonstrate his commitment to exploring nature-derived solutions to public health challenges. Many of these compounds, such as polyphenols and flavonoids, have demonstrated antimicrobial and antiviral properties, making them potential adjuncts in infectious disease treatment. His innovative work on encapsulation technology—particularly nanoemulsions and double emulsions—has enabled targeted delivery of these compounds, enhancing their stability and efficacy. These advances have broad implications in the management of bacterial and viral foodborne illnesses, especially in vulnerable populations. His research is widely published in high-impact journals, evidencing both depth and breadth. Through projects like yogurt fortified with inulin or camel milk enhanced with probiotics, he combines scientific rigor with nutritional foresight. His exploration of shelf-life enhancement and preservation methods directly addresses contamination and disease spread in perishable goods. Such applications play a crucial role in food systems resilience against pathogens, including those that cause enteric infections. His work positions food not only as sustenance but as a strategic platform for disease intervention.

🧫 ADVANCES IN INFECTIOUS DISEASE TREATMENT VIA FOOD SCIENCE

Professor Chouaïbi's contributions have extended beyond traditional food science into the realm of infectious disease treatment and prevention. His application of bioactive-rich emulsions and coatings—such as thyme essential oil encapsulation and almond gum films—offers a sustainable, chemical-free alternative to conventional disinfectants. These formulations are especially effective against microbial spoilage and contamination, which are common vectors for infectious disease transmission through food. His collaborations have resulted in yogurt enriched with antimicrobial agents and functional cheeses with targeted probiotic properties, both of which support gastrointestinal health and immunological defense. His work on modeling urease activity reduction in soybean meals and optimizing drying processes has clinical relevance in reducing pathogen viability. Furthermore, his patents on emulsifiers and encapsulation systems are setting new standards in controlled delivery of anti-pathogenic agents. As diseases evolve and antibiotic resistance grows, the integration of food engineering in the fight against infections becomes increasingly vital. Through his food-based biotechnological innovations, Professor Chouaïbi is contributing practical tools that align nutrition with infection control, reinforcing the interdisciplinary bridge between food technology and public health.

📚 EDITORIAL AND SCHOLARLY IMPACT

Beyond research and teaching, Professor Chouaïbi holds influential editorial roles in several international journals including Discover Food, Journal of Food Measurement and Characterization, and Frontiers in Materials. These positions affirm his global recognition as an authority in food engineering. His role as guest editor and board member enables him to shape emerging discourses around sustainable food systems, food safety, and biofunctional ingredients. He has authored multiple books and book chapters that explore food preservation technologies, phytochemicals, and encapsulation techniques—many of which serve as reference texts in food and nutrition science. His scholarly contributions provide critical frameworks for understanding how food technology can mitigate microbial risks. Through peer review and journal leadership, he fosters innovation, ensures scientific rigor, and promotes cross-border collaborations. This academic leadership enhances not just his personal standing but also the integrity and visibility of food science research in developing infectious disease interventions. By mentoring young scientists and influencing research directions globally, Professor Chouaïbi multiplies his impact, ensuring the continuity and evolution of science-based solutions to pressing health threats.

🏆 HONORS, PATENTS & INTERNATIONAL COLLABORATIONS

Professor Moncef Chouaïbi’s excellence has been acknowledged through various honors, patents, and extensive international engagements. He is a patent holder for technologies including novel emulsifiers for drug delivery and food coating systems with bioactive properties, which support food safety and infectious disease mitigation. These innovations provide scalable solutions for controlling contamination in food supply chains. His scientific influence spans across borders with collaborative research in Italy, Japan, and across North Africa. Participation in international conferences—from the Euro-Global Conference on Food Science to Japan-Tunisia symposia—underscores his reputation as a global expert. His patented work on the use of natural polymers and biopolymers in preserving food integrity has found use in both academic and industrial settings. These achievements not only validate his research but also position his methodologies as models for innovation in developing antimicrobial systems from food matrices. His multidisciplinary patents have crossover value in pharmaceuticals, nutraceuticals, and environmental safety. These accolades represent the fusion of his engineering ingenuity with a vision for healthier communities.

🌍 LEGACY & FUTURE CONTRIBUTIONS TO GLOBAL HEALTH

Looking ahead, Professor Chouaïbi is poised to further integrate food engineering with global health initiatives. His future research aims to refine nanoencapsulation methods to deliver targeted nutritional therapies and anti-infective agents through everyday food products. His commitment to addressing malnutrition, microbial contamination, and diet-related diseases aligns with global health goals and sustainable development frameworks. By developing bioactive-rich ingredients from agricultural waste, he also promotes circular economy principles and food system sustainability. His work resonates deeply in low- and middle-income countries, where accessible, nutrition-based interventions are critical in combating infectious disease burdens. As a mentor and innovator, his legacy will extend through the scientists he inspires, the institutions he shapes, and the communities that benefit from his science. With over 50 peer-reviewed articles and involvement in cutting-edge international projects, Professor Chouaïbi's contribution to the intersection of food science and infectious disease control is both transformative and enduring. His vision positions food not just as nourishment, but as a strategic frontier in the fight against infectious diseases worldwide.

NOTABLE PUBLICATION

  • Title: Co-encapsulation of catechin and L-lysine in water-in-oil-in-water (W1/O/W2) double emulsion using membrane emulsification process: application in carrot based infant-purée
    Authors: Eya Soussi, Nayrouz Yahyaoui, Moncef Chouaibi, Salem Hamdi
    Journal: Journal of Food Measurement and Characterization
    Year: 2025

 

  • Title: Comparative study of Acacia tortilis subsp. raddiana gum of Tunisian origin and commercial Acacia senegal gum
    Authors: Khouloud Rigane, Moncef Chouaibi, Romdhane Karoui
    Journal: Journal of Food Measurement and Characterization
    Year: 2025

 

  • Title: Arbutus unedo fruit syrup as a fortifying agent: effect on physicochemical, microbiological, rheological, sensory and antioxidant properties of yoghurt
    Authors: I. Essaidi, M. Chouaibi, H. Haj Koubaier, S. Bouacida, A. Snoussi, Y. Abassi, N. Bouzouita
    Journal: Journal of Food Science and Technology
    Year: 2023

 

  • Title: Bioactive Phytochemicals from Pumpkin Seed Oil Processing By-products
    Authors: L. Rezig, K. Gharsallah, M. Chouaibi
    Journal: Reference Series in Phytochemistry (Book Chapter)
    Year: 2023

 

  • Title: Influence of Conservation Agriculture on Durum Wheat Grain, Dough Texture Profile and Pasta Quality in a Mediterranean Region
    Authors: I. Kerbouai, D. Sfayhi, K. Sassi, H.C. M’hamed, H. Jenfaoui, J. Riahi, S. Arfaoui, M. Chouaibi, Ben-... (author name appears truncated)
    Journal: Agriculture (Switzerland)
    Year: 2023

Bidyut Matubber – Antibiotic – Best Researcher Award

Published on by Infectious

Bidyut Matubber - Antibiotic - Best Researcher Award

Khulna Agricultural University - Bangladesh

AUTHOR PROFILE

GOOGLE SCHOLAR 

EARLY ACADEMIC PURSUITS 🎓

Dr. Bidyut Matubber’s academic foundation is deeply rooted in veterinary public health and food hygiene. He completed his Doctor of Veterinary Medicine (DVM) in 2017 from Patuakhali Science and Technology University, securing a commendable CGPA of 3.74. Demonstrating his passion for advanced learning, he pursued a Master of Veterinary Public Health and Food Hygiene with a major in Antimicrobial Resistance, graduating with a perfect CGPA of 4.00 in 2019. These formative years reflect a consistent commitment to academic excellence and laid the groundwork for his specialization in food microbiology. During his master's tenure, Dr. Matubber actively participated in hands-on research activities, including antibiogram studies and chromatographic analysis. His academic environment exposed him to a multidisciplinary research setting, fostering a deeper understanding of microbiological threats in food systems. This exposure played a pivotal role in shaping his career and interest in public health. With a solid base in microbiology, statistics, and biosafety, he was well-prepared to address complex public health concerns, particularly those linked to antimicrobial resistance. His early academic journey was not just a pursuit of degrees but a strategic investment toward a research-intensive future in veterinary science and food safety, setting the stage for his impactful contributions.

PROFESSIONAL ENDEAVORS 🧪

Dr. Bidyut Matubber’s professional career commenced with a focused approach toward academia and applied research. Since November 2020, he has been serving as an Assistant Professor in the Department of Microbiology and Public Health at Khulna Agricultural University. In this role, he spearheads research on antimicrobial resistance and chemical residues in food items such as meat and milk. His work extends to critical extension activities, strengthening collaboration between universities, research institutions, and livestock farmers. His contributions aim to bridge the gap between scientific discoveries and practical applications in food safety. Prior to this, Dr. Matubber held the position of Master Research Fellow at his alma mater, where he honed his research skills in statistical software such as SPSS and R. He has also undergone extensive training in laboratory biosafety, surveillance, foot-and-mouth disease investigation, and herd production management. These multidimensional experiences enrich his capacity as both a researcher and educator. Dr. Matubber is not confined to the laboratory; his outreach and on-ground surveys enable him to assess real-world challenges faced by food handlers and animal health workers. His professional endeavors reflect a dynamic balance between rigorous research and meaningful community engagement, ensuring relevance and impact in every project he undertakes.

RESEARCH CONTRIBUTIONS AND FOCUS 🔬

Dr. Bidyut Matubber’s research trajectory is anchored in the critical domains of antimicrobial resistance (AMR), food microbiology, and public health. His work scrutinizes the presence of antibiotic resistance and chemical residues in livestock products — particularly meat and milk — in southern Bangladesh. His findings have been published in several reputable national and international journals, reinforcing his reputation as a dedicated scientific voice in the food safety sector. Notably, his recent studies explore the microbial contamination of street foods and the prevalence of multidrug-resistant pathogens in urban meat markets. These investigations have significant implications for public health, especially in developing countries grappling with poor food hygiene infrastructure. Dr. Matubber is also a contributing author in interdisciplinary topics, ranging from student mental health during online learning to reproductive issues in livestock. His collaborative research style has earned him co-authorship with international scholars and local experts, highlighting the diverse scope of his academic inquiries. Moreover, his work on biofilm resistance in farm industries and the evaluation of organic acid alternatives to antibiotic growth promoters reflect his forward-thinking approach. Altogether, his research contributions aim not just to describe problems but to offer actionable, evidence-based solutions in public health microbiology.

AWARDS AND RECOGNITION 🏆

Dr. Bidyut Matubber’s exemplary contributions to veterinary public health and food microbiology have been widely acknowledged through prestigious accolades. He was awarded the NST Research Fellowship (2019) by the Ministry of Science and Technology, Bangladesh — a competitive grant that recognized his potential in the field of antimicrobial resistance. In 2020, he won the Best Poster Presentation Award at the 3rd Annual Scientific Conference organized by the Coastal Vet Society of Bangladesh, showcasing his ability to communicate research effectively to scientific audiences. Further acknowledging his innovation and commitment, the Ministry of Science and Technology honored him with the Technology Invention, Research, and Development Project (R&D) grants in both 2021 and 2022. Perhaps most significantly, he received the Best Researcher Award (2022) from the Khulna Agricultural University Teacher’s Association for his outstanding scholarly accomplishments. These accolades are not just ceremonial; they are powerful affirmations of Dr. Matubber’s enduring influence in microbiology and public health research. They reflect his relentless pursuit of scientific excellence, impactful community engagement, and forward-looking research that addresses urgent food safety challenges in Bangladesh. Each award underlines a milestone in his evolving career, cementing his place as a key thought leader in his domain.

IMPACT AND INFLUENCE 🌍

Dr. Matubber's research has far-reaching implications for public health policy and food safety in Bangladesh. His work on antimicrobial resistance in meat and milk serves as a wake-up call for food safety regulators and veterinary policymakers. By highlighting the presence of drug-resistant bacteria in widely consumed animal products, his studies provide a critical evidence base for shaping food inspection protocols and public awareness campaigns. Beyond his published findings, Dr. Matubber plays a pivotal role in academic and field-level training, educating young researchers and practitioners about biosafety, food hygiene, and AMR surveillance. His influence also extends into interdisciplinary domains, as seen in his co-authored work on student anxiety during e-learning and reproductive health in livestock. Dr. Matubber's ability to synthesize data into policy-relevant recommendations amplifies his impact beyond academia. As a faculty member, he actively mentors future scientists and contributes to the university's knowledge-sharing platforms. His integrated approach — combining lab research, fieldwork, teaching, and publication — creates a ripple effect of influence across public health, education, and rural livelihoods. Through conferences, training programs, and collaborative networks, Dr. Matubber continues to shape not only scientific discourse but also the operational realities of food safety and veterinary health in Bangladesh.

LEGACY AND FUTURE CONTRIBUTIONS 🔭

Dr. Bidyut Matubber’s academic journey and professional milestones lay the foundation for a legacy marked by scientific integrity, community relevance, and transformative impact. Looking ahead, he is poised to expand his research into broader themes like the environmental reservoirs of antimicrobial resistance, molecular epidemiology, and climate-linked zoonotic diseases. His ongoing projects involving the contamination levels in street food and multidrug-resistant pathogens in meats are likely to evolve into larger surveillance frameworks with regional or national scope. Moreover, Dr. Matubber envisions integrating genomic tools and AI-driven analytics into his research to better understand resistance mechanisms. As a faculty member, he aims to establish a specialized research hub within Khulna Agricultural University that focuses on foodborne pathogens and antibiotic resistance. His long-term goals include mentoring doctoral candidates and fostering international research collaborations, particularly in South Asia and Southeast Asia. With his background in both laboratory and field-based research, Dr. Matubber is ideally positioned to contribute to global initiatives like the WHO's One Health framework. His legacy will not only be defined by his publications or awards, but by the structural improvements he brings to food safety systems, academic training, and public health policies in Bangladesh and beyond.

SUMMARY OF ACHIEVEMENTS 🧾

Dr. Bidyut Matubber is a dynamic academic, microbiologist, and public health researcher based at Khulna Agricultural University. With over five years of expertise in food microbiology and antimicrobial resistance, his work has led to impactful research on contamination in meat, milk, and street foods across southern Bangladesh. He has co-authored numerous papers in reputed journals, participated in national training programs, and successfully acquired competitive grants. His professional tenure includes key roles as an Assistant Professor and Master Research Fellow, underscoring a consistent trajectory of growth. Recognized for both scientific innovation and practical relevance, he has received prestigious awards, including the NST Research Fellowship and the Best Researcher Award by his university. His research has informed public policy and raised awareness about food safety issues in underserved communities. By combining rigorous lab work, strategic field outreach, and teaching excellence, Dr. Matubber exemplifies a researcher whose work transcends academia to affect real-world change. His story is one of perseverance, interdisciplinary collaboration, and a passionate commitment to improving health outcomes through science.

NOTABLE PUBLICATION

  • Title: Anxiety and its determinants among undergraduate students during E-learning in Bangladesh amid COVID-19
    Authors: MN Hoque, A Hannan, S Imran, MA Alam, B Matubber, SM Saha
    Journal: Journal of Affective Disorders Reports, Volume 6, Article 100241, 2021

 

  • Title: Factors associated with food safety knowledge and practices among meat handlers in Bangladesh: a cross-sectional study
    Authors: MH Al Banna, TR Disu, S Kundu, BO Ahinkorah, K Brazendale, AA Seidu, ...
    Journal: Environmental Health and Preventive Medicine, Volume 26, Article 84, 2021

 

  • Title: Pernicious attitude of microbial biofilms in agri-farm industries: Acquisitions and challenges of existing antibiofilm approaches
    Authors: SH Toushik, A Roy, M Alam, UH Rahman, NK Nath, S Nahar, B Matubber, ...
    Journal: Microorganisms, Volume 10, Issue 12, Article 2348, 2022

 

  • Title: Evaluation of different parameters in relation to repeat breeding of cows at the coastal areas of Bangladesh
    Authors: B Matubber, AK Paul, S Das
    Journal: Research in Agriculture Livestock and Fisheries, Volume 5, Issue 1, Pages 49–55, 2018

 

  • Title: Antibiotic resistance and residue in chicken, cattle, buffalo and goat meats in different southern districts of Bangladesh
    Authors: B Matubber, FI Rume, MEH Kayesh, MM Rahman, MR Amin, MA Asgar, ...
    Journal: Asian-Australasian Journal of Food Safety and Security, Volume 5, Issue 1, Pages 19–26, 2021

Qingshuang Wang – Diagnosis of Infectious Diseases – Best Researcher Award

Published on by Infectious

Qingshuang Wang - Diagnosis of Infectious Diseases - Best Researcher Award

Changchun University of Science and Technology - China

AUTHOR PROFILE 

SCOPUS

ROOTS AND ACADEMIC FOUNDATION 🌱

Wang Qingshuang hails from Shuangyashan City in Heilongjiang Province. His academic journey began at Harbin Normal University, where he graduated from the Department of Biology in 2002. Driven by a deep curiosity in scientific advancement, he pursued a Ph.D. in Optics from the Changchun University of Science and Technology, completing it in 2015. His educational path blends biological sciences and optical research—an intersection that would later define his unique research pursuits. In 2005, he broadened his academic experience at Peking University School of Medicine, further shaping his research trajectory. Later, as a visiting scholar at the University of British Columbia in 2017, he gained international exposure, which enriched his scientific outlook. These early academic experiences cultivated a strong foundation for his multidisciplinary research career, particularly in molecular biology, nanotechnology, and biomedical optics.

SCIENTIFIC CAREER AND LEADERSHIP 🧪

Currently, Professor Wang Qingshuang serves as Vice Dean, Professor, and Doctoral Supervisor at the School of Life Sciences and Technology, Changchun University of Science and Technology. His academic roles are bolstered by his active participation in national scientific committees and provincial technology initiatives. As a dissertation and project reviewer, he contributes significantly to educational and scientific standards. His leadership extends into professional organizations such as the Jilin Society of Biochemistry and Molecular Biology and the Innovation and Translational Medicine Professional Committee. Professor Wang not only teaches but also mentors young researchers and supervises Ph.D. students, helping cultivate the next generation of scientific minds. His role as an executive and committee member in several scientific societies underlines his influence in shaping policy and research priorities in biochemistry, molecular diagnostics, and applied biotechnology across Jilin Province and beyond.

INNOVATION IN RESEARCH AND BIOMEDICAL TECHNOLOGY 🔬

With over a decade of research in nano-sustained-release and anti-tumor drugs, Professor Wang Qingshuang has made significant strides in biomedical innovation. His work integrates optical science with molecular biology to create effective delivery systems for therapeutic agents. As a principal investigator, he led a basic scientific research project under the State Administration of Science, Technology and Industry for National Defense and contributed to two National Natural Science Foundation projects. His portfolio includes more than ten key R&D projects in Jilin Province, underscoring his leading role in regional biotech innovation. With over 20 SCI-indexed publications and many more in EI and core journals, Professor Wang’s scientific output reflects both depth and practical impact. His unique approach bridges fundamental science with real-world medical applications, exemplifying the translational potential of interdisciplinary research in drug development and diagnostic systems.

COMBATING COVID-19 WITH SCIENCE 🦠

In 2020, amidst the COVID-19 pandemic, Professor Wang Qingshuang emerged as a key scientific contributor in China’s fight against the virus. Leading his team as the technical head, he developed and implemented droplet digital PCR technology for nucleic acid detection of the novel coronavirus. This advanced diagnostic tool significantly improved detection accuracy and efficiency. In a show of solidarity, Professor Wang's team donated these kits to frontline institutions such as West China Hospital of Sichuan University and People's Hospital of Wuhan University. His leadership and quick response not only aided immediate clinical efforts but also reinforced the value of rapid scientific mobilization during global health crises. For these efforts, his research group—the “Jilin Province Cross-Regional Gene Diagnosis Frontier Technology Science and Technology Innovation and Entrepreneurship Team”—received national recognition from the Ministry of Science and Technology for outstanding contributions in epidemic response.

HONORS AND SCHOLARLY RECOGNITION 🏅

Professor Wang Qingshuang’s research excellence has been celebrated with numerous accolades. He is a two-time recipient of the Jilin Province Science and Technology Award, a prestigious honor recognizing innovation and impact in scientific research. His mentorship in undergraduate innovation has also earned him several first and second prizes in the National Undergraduate Life Science Innovation and Entrepreneurship Competition, highlighting his dedication to education and student development. These awards not only affirm his scientific achievements but also showcase his commitment to fostering young talent in the life sciences. Moreover, his esteemed roles as a reviewer for national academic dissertations and technological projects reflect the scholarly community’s trust in his expertise. These cumulative recognitions illustrate a career defined by both intellectual rigor and influential guidance across the fields of life sciences, diagnostics, and medical biotechnology.

SCIENTIFIC IMPACT AND PUBLIC SERVICE 🌍

Beyond academic circles, Professor Wang Qingshuang’s work has had a measurable impact on public health and scientific policy. His COVID-19 diagnostic innovations directly contributed to safer and more accurate detection methods during a time of urgent global need. As a public contributor, he aligns scientific advancement with societal benefit, often integrating his research with regional health initiatives and policy-making through his role in the Jilin Health Management Society. His position at the interface of research, clinical application, and public welfare allows him to influence how science serves humanity. His vision combines high-level scientific rigor with real-world applications, improving not only patient outcomes but also strengthening regional research infrastructure. Through these actions, Professor Wang embodies the role of a scientist as both a discoverer and a servant of the public good.

LEGACY AND FUTURE ASPIRATIONS 🚀

Looking forward, Professor Wang Qingshuang aims to expand the frontiers of biomedical diagnostics and nano-drug delivery systems. His legacy is being etched not only in academic literature but also in the generation of scientists he mentors and the technological platforms he pioneers. As he continues to collaborate with national and international institutions, his research is expected to reach broader clinical applications and influence global healthcare innovation. He envisions building interdisciplinary laboratories that integrate optics, nanotechnology, and molecular medicine, paving the way for precision diagnostics and therapies. His commitment to translational science ensures that future endeavors will continue to bridge the gap between research labs and hospital wards. With an unrelenting passion for inquiry and innovation, Professor Wang is poised to leave a lasting mark on biomedical science and public health advancement.

NOTABLE PUBLICATION

Title: Fe₂VO₄@N−C cathode for high performance aqueous zinc and ammonium-ion batteries
Authors: Yinqiang Hu, Li Lin, Zhenyu Hu, Qingshuang Wang, Chunpeng Yang
Journal: Not specified (journal name not shown in the provided text)

Title: An electrochemical biosensor based on a novel nucleic acid isothermal amplification method for detecting pathogenic bacteria
Authors: Chuanna Xu, Shengjun Bu, Boyuan Jian, Qingshuang Wang, Jiayu Wan
Journal: Microchemical Journal, 2025

Title: High capacity and efficient dehydrogenation of aluminum hydride: Optimized by highly active TiN nanoparticles with low addition
Authors: Shaolei Zhao, Qingyun Shi, Long Liang, Limin Wang, Yong Cheng
Journal: Nano Research, 2025

Title: Thermosensitive Hydrogel Loaded with α-Mangostin for Enhanced Antitumor Effect of Doxorubicin
Authors: Tianhui Liu, Qingshuang Wang, Wenxin Geng, Zhe Zhang, Xiangru Feng
Journal: ACS Biomaterials Science and Engineering, 2025

Title: Nano-Based Strategies Aiming at Tumor Microenvironment for Improved Cancer Therapy
Authors: Tianhui Liu, Changshun Lu, Xue Jiang, Xiangru Feng, Qingshuang Wang
Journal: Not specified (journal name not shown in the provided text)

Somdeb Bose Dasgupta – Microbial Pathogenesis and Virulence – Best Researcher Award

Published on by Infectious

Somdeb Bose Dasgupta - Microbial Pathogenesis and Virulence - Best Researcher Award

IIT Kharagpur - India

AUTHOR PROFILE 

SCOPUS

EARLY ACADEMIC PURSUITS 🎓

Dr. Somdeb Bose Dasgupta began his scientific journey with a B.Sc in Physiology, Chemistry, and Zoology from City College, University of Calcutta, graduating with first-class honors in 2001. He pursued an M.Sc in Biophysics & Molecular Biology from Rajabazar Science College, University of Calcutta, and again secured first-class distinction. His academic rigor culminated in a Ph.D. in Molecular Parasitology from CSIR-IICB and Jadavpur University in 2009, where he was awarded the Best Thesis Award. During his doctoral years, Dr. Dasgupta delved deep into the molecular machinery of parasitic organisms, setting the foundation for a career that would be defined by his dedication to host-pathogen interactions. The exceptional clarity and originality of his doctoral research earned him early recognition in India’s scientific community, establishing a trajectory toward pioneering work in infectious diseases and immunology, especially concerning neglected tropical diseases like Leishmaniasis and Tuberculosis.

PROFESSIONAL ODYSSEY 🌍

Following his doctorate, Dr. Dasgupta expanded his scientific horizon through a postdoctoral fellowship at the University of Basel’s Biozentrum in Switzerland, from 2009 to 2014, where he worked on macrophage-pathogen interactions. This global exposure refined his research methodologies and enriched his understanding of molecular immunology. He then returned to India to contribute as an Assistant Professor at IIT (BHU) Varanasi from 2014 to 2016, before joining IIT Kharagpur in the Department of Biotechnology in 2016. At IIT Kharagpur, he rose to the position of Assistant Professor Grade I and became a pivotal figure in both undergraduate and postgraduate teaching. His courses span Molecular Biology, Neurophysiology, Biochemistry, and Bioprocess Engineering, nurturing the next generation of biotechnologists. His professional odyssey reflects a balance between international research excellence and a deep-rooted commitment to Indian scientific development. Throughout, he has maintained a clear vision: to translate basic science into therapeutic and diagnostic breakthroughs against life-threatening infectious diseases.

RESEARCH FOCUS 🔬

Dr. Dasgupta’s research lies at the intersection of molecular immunology, cellular microbiology, and genome editing. His lab investigates host-pathogen dynamics, especially in Mycobacterium tuberculosis and Leishmania donovani infections—diseases of critical importance to the Indian subcontinent. Utilizing CRISPR/Cas9 technologies, his team uncovers how host enzymes, particularly kinases and phosphatases, are manipulated by pathogens to ensure survival. His group is innovating host-directed therapeutics to bypass drug resistance by reactivating immune responses and restoring macrophage functionality. His approach includes drug repurposing strategies—like testing tricyclic antidepressants for anti-leishmanial use—and developing novel diagnostics for drug-resistant TB. Additionally, Dr. Dasgupta studies how parasitic infections influence phagosome maturation and immune modulation. His projects explore everything from biochemical pathway elucidation to advanced nanocarrier-based drug delivery systems. By combining cellular, biochemical, and genomic strategies, his lab offers crucial insights into both fundamental disease biology and translational medicine, with the aim of improving public health outcomes across endemic regions.

PIONEERING CONTRIBUTIONS 🧪

Over his career, Dr. Dasgupta has contributed over 38 research articles, five book chapters, and 25 conference proceedings, with many featured in high-impact journals like PNAS, FEBS Journal, and PLOS Pathogens. His pioneering findings—such as the discovery of how S-nitrosylation of mycobacterial Protein Kinase G (PknG) aids pathogen survival—have received global attention, including journal cover highlights and editor’s choice selections. At the forefront of translational research, he developed groundbreaking assays to study host-pathogen phospho-signaling, designed nanocarrier systems for immunomodulatory drug delivery, and repurposed common drugs into potential antiparasitic treatments. His innovations in CRISPR-based gene editing of host and pathogen genomes have redefined therapeutic targets. Further, his role in establishing India’s hybrid BSL-III facility at IIT Kharagpur has paved the way for safe, cutting-edge research on high-risk pathogens. Collectively, Dr. Dasgupta’s work bridges discovery and application, positioning him as a vanguard of molecular parasitology and infectious disease biology.

AWARDS AND RECOGNITION 🏅

Dr. Dasgupta’s scholarly excellence has been widely acknowledged. He was honored with the prestigious INSA Young Scientist Award in 2011 for contributions to biophysics and biochemistry, followed by the coveted DBT-Ramalingaswamy Fellowship in 2015. His postdoctoral research earned him the EMBO Long Term Fellowship in 2009, reflecting international acclaim. He has received multiple Best Poster Awards at national and international symposia, including the Annual Post-doc Retreats in Switzerland and the National Congress of Parasitology in India. His publications have been featured on journal covers and spotlighted for editorial distinction. He also received a DBT-CTEP Travel Award to attend the World Congress in Infectious Diseases in London, showcasing his global scientific presence. These accolades underscore both the depth and societal impact of his research. Through sustained excellence in discovery, innovation, and mentorship, Dr. Dasgupta has become a beacon in the field of molecular microbiology and immunopathology, inspiring peers and proteges alike.

IMPACT AND INFLUENCE 🌐

Dr. Dasgupta’s influence extends beyond laboratory research into public health, diagnostics, and therapeutic development. His contributions are instrumental in tackling antimicrobial resistance—one of modern medicine’s gravest challenges. By advancing host-directed therapies and creating rapid point-of-care diagnostic tools, he directly impacts clinical strategies for TB and Leishmaniasis. His leadership in major government-funded projects—ranging from ICMR, DST, DBT, to SERB—demonstrates trust in his ability to deliver translational outcomes. His work has informed national health priorities and contributed to India’s strategic push toward self-reliance in infectious disease control. As a mentor and educator, he shapes future scientists, embedding translational thinking in their academic DNA. His integrated approach, which combines molecular biology, nanotechnology, and immunology, sets a benchmark for interdisciplinary biomedical research in India. Through his visionary projects and collaborations, Dr. Dasgupta is not only solving today's biomedical problems but also laying the groundwork for long-term scientific resilience and healthcare innovation.

LEGACY AND FUTURE HORIZONS 🚀

Dr. Dasgupta’s legacy lies in transforming how we understand and combat chronic infectious diseases in resource-limited settings. His work champions a paradigm shift—from pathogen-centric drug design to host-targeted intervention, which offers sustainable solutions in the face of evolving drug resistance. The upcoming years promise even greater impact: his team is pioneering biosensors for non-invasive TB detection and leveraging liposomal drug delivery platforms for improved efficacy. With multiple ICMR-backed projects underway, including ENLIGHTEN—a non-invasive latent TB detection initiative—Dr. Dasgupta continues to chart untraveled paths in diagnostic science. He also plays a central role in shaping high-containment laboratory infrastructure to safely study dangerous pathogens. His foresight, collaborative spirit, and relentless pursuit of translational relevance ensure that his contributions will endure in both academic and clinical domains. Dr. Somdeb Bose Dasgupta is poised to remain a cornerstone of biomedical innovation, where his science continues to illuminate pathways toward global health equity.

NOTABLE PUBLICATION 

 Article Title:
Resolving the polycistronic aftermath: Essential role of topoisomerase IA in preventing R-loops in Leishmania
Authors: P. Das, A. Hazra, S. Saha, H.K. Majumdar, S. BoseDasgupta
Journal: The Journal of Biological Chemistry, 2024

 Article Title:
Gelatin-decorated Graphene oxide: A nanocarrier for delivering pH-responsive drug for improving therapeutic efficacy against atherosclerotic plaque
Authors: S.K. Yadav, S. Das, A. Lincon, S.K. Ray, S.C. Das
Journal: International Journal of Pharmaceutics, 2024